SCHEMBL22495261

SCHEMBL22495261

COc1ccc(C(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.55
LMNA P02545 3/20 0.55
MAPT P10636 8/20 0.52
ALDH1A1 P00352 7/20 0.52
KMT2A Q03164 3/20 0.52
KDM4E B2RXH2 2/20 0.52
MCL1 Q07820 2/20 0.52
GLA P06280 1/20 0.52
RAB9A P51151 5/20 0.51
NPC1 O15118 4/20 0.51
MAPK1 P28482 2/20 0.51
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
GAA P10253 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
NR4A1 P22736 1/20 0.50
F10 P00742 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31504234 1.00 NAMPT (0.55) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL31504220 0.90 L3MBTL1 (0.60) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL22495302 0.90 L3MBTL1 (0.60) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL22495244 0.89 LMNA (0.54) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL31504183 0.89 LMNA (0.54) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL22495279 0.88 ALDH1A1 (0.48) NAMPTLMNAALDH1A1KMT2AKDM4E
SCHEMBL31504186 0.88 ALDH1A1 (0.48) NAMPTLMNAALDH1A1KMT2AKDM4E
SCHEMBL22495206 0.87 ALDH1A1 (0.52) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL31504295 0.87 ALDH1A1 (0.52) NAMPTLMNAMAPTALDH1A1KMT2A
SCHEMBL21771103 0.87 RAB9A (0.68) NAMPTLMNAMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP claimed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US claimed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US claimed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN claimed
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
EP-3728234-A1 RADIOLABELED COMPOUNDS F. Hoffmann-La Roche AG (CH) 2020-10-28 EP disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11541132-B2 Radiolabeled compounds SNCA, APP, BACE1 NAMPT 4030/4885LMNA 1833/4885MAPT 16/4885
US-20200316232-A1 RADIOLABELED COMPOUNDS SNCA, APP, BACE1 NAMPT 4265/4885LMNA 1770/4885MAPT 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.